Gaucher disease – more than just a rare lipid storage disease Gaucher disease (GD), one of the most common lysosomal storage diseases, is caused by mutations in the gene, GBA1, that leads to defective glucocerebrosidase activity resulting in the accumulation and storage of glycosphingolipids
Gaucher disease - Harvard Health All three types of GD are caused by a change, or mutation, in a gene called GBA, which is responsible for making the glucocerebrosidase enzyme Gaucher disease is an autosomal recessive genetic disorder This means that the person with the disease must inherit two mutations in the gene, one from their mother and one from their father
Gaucher Disease: Background, Pathophysiology, Etiology Gaucher disease is a lipid storage disease characterized by the deposition of glucocerebroside in cells of the macrophage-monocyte system The disorder results from the deficiency of a
Gaucher Disease Overview - Rare Disease Advisor This enzyme breaks down glucocerebroside into glucose and ceramide within the lysosome 1,3 The mutation causes glucocerebrosidase deficiency and leads to glucocerebroside lipid accumulation—mainly in the bone marrow, liver, and spleen—resulting in organ damage, blood cell abnormalities, and hepatosplenomegaly 1
Gaucher disease: Pathogenesis, clinical manifestations, and . . . - UpToDate Gaucher disease (GD) is an inborn error of metabolism that affects the recycling of cellular glycolipids Glucocerebroside (also called glucosylceramide) and several related compounds that are ordinarily degraded to glucose and lipid components accumulate within the lysosomes of cells